Huaqin Wu

637 total citations
34 papers, 412 citations indexed

About

Huaqin Wu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Huaqin Wu has authored 34 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 6 papers in Biomedical Engineering. Recurrent topics in Huaqin Wu's work include Heart Failure Treatment and Management (6 papers), Cardiovascular Function and Risk Factors (5 papers) and Photoacoustic and Ultrasonic Imaging (5 papers). Huaqin Wu is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Cardiovascular Function and Risk Factors (5 papers) and Photoacoustic and Ultrasonic Imaging (5 papers). Huaqin Wu collaborates with scholars based in China and United States. Huaqin Wu's co-authors include Shuqing Shi, Qingqiao Song, Yuanhui Hu, Bingxuan Zhang, Jiayu Lv, Yumeng Li, Wenjing Xue, Xia Xu, Yajiao Wang and Wei Yi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Pharmacological Research.

In The Last Decade

Huaqin Wu

32 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaqin Wu China 12 150 127 55 43 42 34 412
Qingqiao Song China 12 162 1.1× 108 0.9× 41 0.7× 36 0.8× 22 0.5× 29 395
Shintaro Minegishi Japan 15 134 0.9× 205 1.6× 51 0.9× 39 0.9× 41 1.0× 38 516
Inge A. M. van den Oever Netherlands 6 117 0.8× 99 0.8× 56 1.0× 23 0.5× 23 0.5× 7 479
Hengdao Liu China 12 183 1.2× 62 0.5× 72 1.3× 28 0.7× 34 0.8× 26 399
Shanhong Lu China 13 254 1.7× 93 0.7× 37 0.7× 60 1.4× 58 1.4× 24 647
Yangjing Xue China 16 229 1.5× 148 1.2× 97 1.8× 31 0.7× 58 1.4× 36 628
Yasser Mostafa Hafez Egypt 13 164 1.1× 68 0.5× 53 1.0× 42 1.0× 15 0.4× 28 431
Fenghe Du China 13 116 0.8× 98 0.8× 59 1.1× 48 1.1× 13 0.3× 28 386
Yun Ti China 14 202 1.3× 199 1.6× 92 1.7× 30 0.7× 41 1.0× 45 564
Wataru Ohwada Japan 11 211 1.4× 117 0.9× 78 1.4× 28 0.7× 19 0.5× 29 433

Countries citing papers authored by Huaqin Wu

Since Specialization
Citations

This map shows the geographic impact of Huaqin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaqin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaqin Wu more than expected).

Fields of papers citing papers by Huaqin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaqin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaqin Wu. The network helps show where Huaqin Wu may publish in the future.

Co-authorship network of co-authors of Huaqin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Huaqin Wu. A scholar is included among the top collaborators of Huaqin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaqin Wu. Huaqin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Jiayu, Yajiao Wang, Bingxuan Zhang, et al.. (2025). Lingguizhugan decoction ameliorates renal injury secondary to heart failure by improving pyroptosis through TLR4/NF-KB/IRE1α pathway. Phytomedicine. 143. 156862–156862. 2 indexed citations
2.
3.
Zhang, Sijia, et al.. (2024). Novel Perspectives on Chloroplast tRNA Genomic and Structural Variations Imply the Evolution of Papilionoideae (Fabaceae). Horticulturae. 10(9). 932–932. 1 indexed citations
4.
Shi, Shuqing, et al.. (2024). Association of systemic inflammatory markers with clinical adverse prognosis and outcomes in HFpEF: a systematic review and meta-analysis of cohort studies. Frontiers in Cardiovascular Medicine. 11. 1461073–1461073. 4 indexed citations
5.
Wang, Yajiao, Shuqing Shi, Yumeng Li, et al.. (2024). Linking abnormal fat distribution with HFpEF and diastolic dysfunction: a systematic review, meta-analysis, and meta-regression of observational studies. Lipids in Health and Disease. 23(1). 277–277. 4 indexed citations
6.
Lv, Jiayu, Yajiao Wang, Huaqin Wu, et al.. (2024). The role of circulating cytokines in heart failure: a bidirectional, two-sample Mendelian randomization study. Frontiers in Cardiovascular Medicine. 11. 1332015–1332015.
7.
Wang, Yajiao, Shuqing Shi, Xia Xu, et al.. (2023). SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules. SHILAP Revista de lepidopterología. 2. 1109321–1109321. 5 indexed citations
8.
Wang, Yajiao, Shuqing Shi, Yumeng Li, et al.. (2023). Blood urea nitrogen to creatinine ratio and long-term survival in patients with chronic heart failure. European journal of medical research. 28(1). 343–343. 13 indexed citations
9.
Xu, Xia, Bingxuan Zhang, Yajiao Wang, et al.. (2023). Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities. Biomedicine & Pharmacotherapy. 164. 114901–114901. 11 indexed citations
10.
Lv, Jiayu, Shuqing Shi, Xia Xu, et al.. (2023). Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials. BMC Complementary Medicine and Therapies. 23(1). 260–260. 9 indexed citations
11.
Shi, Shuqing, Xinxin Mao, Jiayu Lv, et al.. (2023). Qi-Po-Sheng-Mai granule ameliorates Ach-CaCl2 -induced atrial fibrillation by regulating calcium homeostasis in cardiomyocytes. Phytomedicine. 119. 155017–155017. 13 indexed citations
12.
Lv, Jiayu, Yumeng Li, Shuqing Shi, et al.. (2022). Frontier and Hotspot Evolution in Cardiorenal Syndrome: A Bibliometric Analysis From 2003 to 2022. Current Problems in Cardiology. 48(8). 101238–101238. 14 indexed citations
13.
Shi, Shuqing, Bingxuan Zhang, Yumeng Li, et al.. (2022). Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome. Frontiers in Cardiovascular Medicine. 9. 837270–837270. 15 indexed citations
14.
Xue, Wenjing, Shuqing Shi, Yuan Li, et al.. (2022). Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications. Frontiers in Cardiovascular Medicine. 9. 870924–870924. 41 indexed citations
15.
Xu, Xia, Yumeng Li, Shuqing Shi, et al.. (2022). The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022. Frontiers in Cardiovascular Medicine. 9. 899235–899235. 8 indexed citations
16.
Lv, Jiayu, Shuqing Shi, Bingxuan Zhang, et al.. (2022). Role of puerarin in pathological cardiac remodeling: A review. Pharmacological Research. 178. 106152–106152. 43 indexed citations
17.
Shi, Shuqing, Jiayu Lv, Wenjing Xue, et al.. (2022). Opportunities and Challenges in Cardio-Oncology: A Bibliometric Analysis From 2010 to 2022. Current Problems in Cardiology. 48(8). 101227–101227. 27 indexed citations
18.
19.
Zhang, Xiaoman, et al.. (2019). Photoacoustic identification of blood vessel deformation under pressure. AIP Advances. 9(7). 6 indexed citations
20.
Hu, Yuanhui, et al.. (2017). The relationship between neutrophil to lymphocyte ratio and artery stiffness in subtypes of hypertension. Journal of Clinical Hypertension. 19(8). 780–785. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingqiao Song Breakdown of academic impact, for papers by Shintaro Minegishi Breakdown of academic impact, for papers by Inge A. M. van den Oever Breakdown of academic impact, for papers by Hengdao Liu Breakdown of academic impact, for papers by Shanhong Lu Breakdown of academic impact, for papers by Yangjing Xue Breakdown of academic impact, for papers by Yasser Mostafa Hafez Breakdown of academic impact, for papers by Fenghe Du Breakdown of academic impact, for papers by Yun Ti Breakdown of academic impact, for papers by Wataru Ohwada
Rankless by CCL
2026